GoBroad Hospital

GoBroad Healthcare Group is a leading clinical research-driven hospital group in China, specializing in hematology, oncology, and cell therapy. The group operates a network of specialized hospitals in major cities like Beijing and Shanghai, integrating high-end clinical care with advanced medical research and diagnostic services. GoBroad is particularly recognized for its expertise in hematopoietic stem cell transplantation and CAR-T cell therapy, serving as a critical site for both investigator-initiated and industry-sponsored clinical trials. By maintaining a robust Phase I clinical trial infrastructure and collaborating with global institutions like the Mayo Clinic, the group accelerates the translation of innovative biopharmaceuticals from the laboratory to clinical application. Their multidisciplinary approach focuses on providing precision medicine for patients with complex blood disorders and solid tumors.